Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tianshu Liu
Observed names:
L. Tianshu,
Liu Tianshu
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Zhongshan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Zhongshan Hospital
ORCID:
0000-0002-8604-6311
Observed ORCID:
0000-0002-8604-6311
OpenAlex ID:
A5137191004
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2–Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial
2026
·
Tianshu Liu
, Suxia Luo
, et al.
·
Journal of Clinical Oncology
·
5
Phase 3 trial of trastuzumab rezetecan vs standard of care (SOC) for chemotherapy-refractory, HER2-positive, advanced colorectal cancer (CRC).
2026
·
Jin Li
, Ying Yuan
, et al.
·
Journal of Clinical Oncology
·
3
Phase I/II trial of anti-CLDN18.2/PD-L1 recombinant humanized bispecific antibody Q-1802 plus XELOX in treatment-naive CLDN18.2-positive advanced GC/GEJ.
2026
·
Jifang Gong
, Yakun Wang
, et al.
·
Journal of Clinical Oncology
·
2
A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI /Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer: The NAUTICAL Study
2026
·
Wang Xicheng
, Deng Yanhong
, et al.
·
Cancer Medicine
·
2
Chinese consensus on first-line precision therapy for advanced gastric cancer
2026
·
Xiaotian Zhang
, Weiqi Sheng
, et al.
·
The Innovation
·
2
Nimotuzumab combined with paclitaxel and cisplatin as first-line treatment for metastatic esophageal squamous cell carcinoma: A prospective, multicenter, double-blind, randomized controlled clinical study.
2026
·
Zhihao Lu
, Miaozhen Qiu
, et al.
·
Journal of Clinical Oncology
Abstract 6728: Predicting gastric cancer response to anti-PD-1 first-line treatment based on multi-modal data: A multi-center study.
2026
·
Jingyuan Wang
, Peng Kuang
, et al.
·
Cancer Research
Association between cholesterol and liver injury risk in solid cancer patients treated with PD-1 inhibitors: evidence from two cohort studies
2026
·
Jing Lei
, Yi Wang
, et al.
·
BMC Cancer
229P A single arm, multicenter, phase II trial of oxaliplatin plus capecitabine in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC)
2016
·
L. Tianshu
, Y. Yu
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
9
Citation count:
14
H-index:
2
I10-index:
Year
Topic
Type